Top Smart Glasses for the Visually Impaired (2026): eSight, Envision, OrCam & More

-

Medically & Technically Reviewed by: OneDayMD Editorial Team | Originally Published: August 9, 2026 | Updated: September 2026

Quick Answer

There is no single "best" smart glasses for visual impairment in 2026 — the right pick depends on how much usable vision remains. For low vision (residual central vision from macular degeneration, diabetic retinopathy, or Stargardt disease), medical-grade enhancers like eSight Go ($4,950) or Acesight VR digitally magnify and boost contrast. For blind or near-blind users, AI-interpretation glasses like Envision Glasses ($2,499), Ally Solos (from $399), or a clip-on OrCam MyEye 3 Pro (remaining dealer stock, $3,689–$4,490) read text and describe scenes aloud. The cheapest mainstream option is Meta's expanding AI-glasses lineup — Ray-Ban Meta, Meta Glasses (Adventurer/Fury), and Meta Glasses by Kylie — starting at $299, which isn't purpose-built for accessibility but has become a popular everyday alternative thanks to built-in AI scene description and a Be My Eyes integration. Many devices qualify for VA or vocational-rehabilitation funding, and Meta now gives Ray-Ban Meta glasses free to every legally blind U.S. veteran.

Vision assistance smart glasses are redefining independence for people who are blind or living with low vision. In 2026, advances in on-device AI, lighter optics, and real-time scene understanding have pushed smart glasses far beyond simple magnifiers — while a wave of mainstream AI eyewear, led by Meta and joined this fall by Google and Samsung, has made basic visual assistance dramatically more affordable, even if it isn't a substitute for purpose-built medical devices.

Top Smart Glasses for the Visually Impaired

This guide covers both categories: medical-grade low-vision enhancers and AI-powered smart glasses for the blind, updated with September 2026 pricing, company-status changes, and funding information.

Table of Contents

What Are Vision Assistance Smart Glasses?

Vision assistance smart glasses fall into three practical categories in 2026:

1. Visual Enhancement (Seeing Better)

These devices digitally enhance remaining vision using cameras, zoom, contrast enhancement, and image processing, displayed on near-eye screens.

Best for: users with residual vision — macular degeneration, diabetic retinopathy, Stargardt disease, glaucoma.
Examples: eSight Go, Acesight VR, NuEyes Pro 4 LV, IrisVision Vista

2. Dedicated AI Visual Interpretation (Understanding the World)

Purpose-built assistive devices that use AI to describe scenes, read text aloud, and identify objects, faces, and products — built and tuned specifically for blind and low-vision users.

Best for: blind or near-blind users; navigation, reading, independent daily living.
Examples: Envision Glasses, Ally Solos, OrCam MyEye 3 Pro (while dealer stock lasts)

3. Mainstream AI Glasses

General-consumer smart glasses — not marketed as medical or assistive devices — that happen to work well for vision assistance because of built-in AI scene description and OCR. Meta now leads with three sub-brands (Ray-Ban Meta, the self-branded Meta Glasses, and Meta Glasses by Kylie), and Google and Samsung are entering the category with Android XR glasses launching this fall. The American Foundation for the Blind has described this class of device as, in effect, an accessibility tool by coincidence rather than by design — less specialized than dedicated devices, but far more affordable and more discreet.

2026 Comparison at a Glance

Device Category Price (Sept. 2026) Best For
eSight Go Visual enhancement $4,950 MSRP Central vision loss, moderate-severe low vision
Envision Glasses Dedicated AI $2,499 (Home Edition) Blind/near-blind, full-feature reading & navigation
Ally Solos Glasses Dedicated AI (budget) From $399 All-day wear, budget-conscious users
OrCam MyEye 3 Pro Dedicated AI (clip-on) $3,689–$4,490 (dealer stock) Discreet, no headset — buy aware of company status below
Ray-Ban Meta / Meta Glasses / Meta Glasses by Kylie Mainstream AI From $299 Everyday use, budget, wanting normal-looking glasses
Acesight VR Visual enhancement ~$3,500–$4,500 Indoor use, wide field of view
NuEyes Pro 4 LV Visual enhancement + AR ~$4,000+ Hybrid work/social use, captioning
IrisVision Vista Visual enhancement (voice-first) Contact for pricing; VA-covered for qualifying veterans Hands-free voice control, NIH-backed research

Pricing varies by dealer, region, prescription add-ons, and financing plan. Confirm current pricing with the manufacturer or an authorized distributor before purchase.

Best Smart Glasses for Vision Assistance in 2026

eSight Go — Best for True Visual Enhancement

eSight Go is a medical-grade low-vision device designed to help users with significant central vision loss actually see more clearly, rather than describing the scene aloud. eSight was acquired by automotive-safety-tech company Gentex in January 2024 and continues to operate as an active product line, with Gentex still demonstrating eSight at CES as recently as January 2026 and pushing regular over-the-air software updates (version 5.3 shipped in June 2026).

Key features

  • High-speed, high-definition front-facing camera with smart autofocus
  • Dual OLED near-eye displays for full binocular enhanced vision
  • Adjustable zoom, contrast, and color filters; helps users from roughly 20/60 to 20/800 visual acuity
  • FDA- and EUDAMED-registered Class I medical device, clinically validated in peer-reviewed studies
  • ~170 g, worn with an adjustable halo band; fits over prescription glasses

Pricing: $4,950 USD MSRP ($6,600 CAD). eSight offers a 7-day at-home trial (Home Experience Program) for $250, credited toward purchase if you keep the device.

Best for: moderate-to-severe low vision, central vision loss, reading, work, and classroom use.
Limitations: high cost; not suitable for totally blind users; not designed for driving.

Envision Glasses — Best Full-Featured AI Assistant for the Blind

Envision Glasses run on Google Glass Enterprise Edition 2 hardware paired with Envision's assistive software and its conversational AI assistant, Ally.

Core capabilities

  • Instant text reading, document scanning, and batch scan mode
  • Scene and environment description; object, color, and face recognition
  • Video calling a trusted companion or an Aira agent for real-time human help
  • Titanium frames, water- and dust-resistant build

Pricing: $2,499 for the Home Edition, which includes a year of software updates (normally $199/year) and a hardware warranty. In April 2026, Envision announced a partnership with Arm and Google to bring more visual AI processing on-device, reducing reliance on the cloud.

Best for: blind or near-blind users who want the widest range of assistive tools in one device.

Ally Solos Glasses — Best Budget All-Day AI Assistance

Ally Solos pairs Envision's Ally AI software with lightweight, audio-first Solos AirGo hardware, at a fraction of the flagship Envision Glasses' price. The product graduated from an August 2025 pre-order campaign to a full public launch through 2026.

Why users like them

  • Launch pricing from $399 — among the most affordable dedicated AI assistive glasses available (list price is $699 once introductory pricing ends, so confirm the current offer before ordering)
  • Up to 16 hours of battery life with swappable, USB-C-charging battery stems
  • Open-ear speakers preserve environmental awareness; under 50 g
  • Connects to the Ally app on iOS/Android (processing happens on your phone, not on the glasses); pre-orders and early buyers get a free year of Ally Pro (a $200 value)

Best for: all-day wear, comfort, and users prioritizing an affordable entry point into dedicated AI glasses.

OrCam MyEye 3 Pro — Best Clip-On Vision Assistant (Read This Before You Buy)

OrCam MyEye is a small, finger-sized AI camera that magnetically clips onto standard eyeglass frames rather than requiring a full headset.

Key benefits

  • Reads text instantly from books, screens, signs, and menus
  • Recognizes faces, products, currency, and colors
  • A "Just Ask" conversational AI assistant, a Smart Magnifier mode, and translation across 140+ languages
  • Gesture-based controls; no bulky headset; offline functionality with no Wi-Fi required

Pricing: $3,689–$4,490 depending on the authorized reseller; 12/18/24-month financing plans are available through some dealers. A supporting 2016 JAMA Ophthalmology study found the underlying wearable device significantly improved daily-living tasks like reading for legally blind participants.

A Note on OrCam's Company Status

OrCam Technologies went through three rounds of layoffs in 2022–2024 and, in July 2024, closed its low-vision R&D department entirely to focus on its hearing-aid line, OrCam Hear — a shift the company attributed partly to smartphone-based AI apps replacing the need for dedicated reading glasses. By 2025 the company had reportedly shrunk to under 50 employees and was described in Israeli tech press as fighting for financial survival amid an investor dispute. In practice, this means the "Just Ask" AI assistant and Smart Magnifier features described above were added back in 2024, not as new 2026 development, and the MyEye 3 Pro units sold today are remaining dealer inventory rather than an actively developed product line. The device itself still works well and is still sold by multiple authorized U.S. resellers at the prices above, but buyers should confirm current warranty terms, repair turnaround, and software-support commitments directly with the dealer before purchasing, since long-term firmware updates are less certain than for a device with active ongoing R&D.

Best for: seniors and anyone wanting discreet, everyday reading and recognition without a visible headset — provided you're comfortable buying a device whose manufacturer has moved on to a different product category.

Meta's AI Glasses Lineup — Best Affordable, Discreet Option

Meta's AI glasses were not designed as medical or assistive devices, but their built-in cameras and Meta AI have made them a genuinely popular option in the blind and low-vision community in 2026 — largely because they look like ordinary eyewear and cost a fraction of dedicated devices. Meta now sells three related lines built with EssilorLuxottica: the original Ray-Ban Meta (Gen 2, from roughly $379), and, since a June 23, 2026 launch, the self-branded Meta Glasses — the rectangular Meta Adventurer and boxier Meta Fury, both from $299 — plus the Kylie Jenner co-designed Meta Glasses by Kylie ("Starfire") at $399. All three share the same camera hardware and Meta AI software (running on Meta's in-house Muse Spark model), so the accessibility-relevant features below apply across the lineup.

Meta introduced Ray-Ban Meta Gen 3 at Meta Connect 2026 on September 23, 2026. The new generation retains the core camera-and-audio architecture while making the glasses slimmer and improving battery life, microphones and controls.

Rayban Meta Gen 3: Available on Amazon

Oakley Meta Vanguard: Available on Amazon

Relevant capabilities

  • Meta AI can describe surroundings, read menus and text aloud, and answer questions about what the camera sees, including a "Live AI" mode for continuous hands-free description.
  • Built-in partnership with Be My Eyes for hands-free calls to sighted volunteers.
  • Dedicated vision-accessibility settings inside the Meta AI app.
  • Prescription lenses available from $224 across most frames.
  • Since June 2026, Meta has been donating free Ray-Ban Meta AI glasses to every legally blind U.S. veteran — more on this in the funding section below.

Pricing: From $299 for Meta Adventurer/Fury, $399 for Meta Glasses by Kylie, and roughly $479 for Ray-Ban Meta Gen 3.

Best for: everyday, budget-conscious use, and anyone who wants assistive features without wearing a visibly "medical" device.

Limitations: not purpose-built for accessibility — no bone-conduction audio tuned for blind users, no dedicated OCR mode, and AI descriptions are less specialized than Envision, OrCam, or Ally Solos for complex low-vision tasks. 

Related: Ray-Ban Meta for Blind and Low Vision Users: Complete 2026 Guide

Acesight VR, NuEyes Pro 4 LV & IrisVision Vista — Mid-Range and Hybrid Options

Acesight VR provides digital magnification (up to 16x) and contrast enhancement via a 48-megapixel camera and a 65° field of view, using a wired handheld controller rather than on-device buttons. It's built for users with roughly 20/100 to 20/600 visual acuity and around 2.5–3 hours of continuous battery life.

NuEyes Pro 4 LV is a fully wireless hybrid device combining low-vision magnification (up to 12x) with OCR text-to-speech and voice control, aimed at macular degeneration, glaucoma, and diabetic retinopathy. It tends to sit at the higher end of the pricing range among visual-enhancement headsets.

IrisVision Vista (formerly IrisVision Live 2.0) is a voice-first, hands-free low-vision headset that grew out of research funded by the National Eye Institute and clinically evaluated at Johns Hopkins' Wilmer Eye Institute. It's controlled entirely by voice or a simple remote, supports a range of magnification and contrast "lenses" for conditions like AMD, retinitis pigmentosa, and Stargardt disease, and — notably — is available at no cost to qualifying veterans through the VA.

All three are worth a demo if you want visual magnification without committing to eSight's price point — though eSight generally offers a wider field of view and longer battery life.

How to Choose the Right Smart Glasses

Do you have usable vision?
Yes → eSight Go, Acesight VR, NuEyes Pro 4 LV, IrisVision Vista (visual enhancement)
No or minimal → Envision Glasses, OrCam MyEye 3 Pro, Ally Solos, Meta's AI Glasses (AI interpretation)

Do you want to see better, or understand your surroundings through audio?
Seeing better → medical-grade low-vision devices
Understanding surroundings → AI smart glasses

What's your budget?
Under $500 → Ally Solos, Meta Adventurer/Fury
$2,000–$3,000 → Envision Glasses
$3,500+ → eSight Go, OrCam MyEye 3 Pro (while stock lasts), Acesight VR, NuEyes

Will you wear them all day?
All-day comfort → Ally Solos, OrCam MyEye 3 Pro, Meta's AI Glasses
Task-specific, higher-power use → eSight Go, Envision Glasses, Acesight VR

Funding, Insurance & VA Coverage

Several devices in this category qualify for outside funding, which materially changes the cost calculation:

  • Veterans: Many VA offices cover eSight Go and IrisVision Vista at little or no cost through a clinician referral. Separately, Meta announced on June 12, 2026 that it would donate free Ray-Ban Meta AI glasses to every legally blind U.S. veteran — an estimated 130,000 people. The program, led by the Blinded Veterans Association with support from groups including the American Council of the Blind, Lighthouse Guild, Tunnel to Towers, and Tech for Troops, kicked off distribution events through the summer of 2026 (including an appearance at the ACB convention in July and a program launch event in Richmond, Virginia in late August). Eligible veterans can apply at bva.org/glasses; nonprofits distributing to members in bulk can apply through TechSoup.
  • Vocational rehabilitation: State vocational rehab programs frequently subsidize OrCam, Envision, and eSight devices for working-age adults, especially when tied to employment goals.
  • Insurance: Some vision-insurance plans partially cover registered blind or low-vision patients for OrCam-class devices — coverage varies significantly by plan and state.
  • Financing: Most manufacturers and authorized dealers (eSight, OrCam resellers, Envision) offer 12–24 month payment plans directly or through partners like Sunbit.

Because funding eligibility depends heavily on your diagnosis, employment status, and location, ask your low-vision specialist or a device's patient-support team what documentation is needed before you buy.

The Future: Android XR, Apple & On-Device AI

By late 2026 and into 2027, expect:

  • Google and Samsung's Android XR glasses — unveiled in preview form at Google I/O in May 2026 and formally shown at Samsung's Galaxy Unpacked event in July 2026, built with eyewear partners Warby Parker and Gentle Monster. An audio-first model without a display remains on track for a fall 2026 launch in select markets (still pending as of this update), with Gemini AI built in for navigation, translation, and object recognition; analyst pricing estimates range from about $379 to $900. A display version is expected to follow in 2027.
  • Apple's first smart glasses have slipped from an originally reported late-2026 reveal: as of Bloomberg reporting in July 2026, Apple is now targeting a reveal at WWDC in June 2027, with retail availability by the end of that year. The device, codenamed N50, is expected to include cameras, microphones, speakers, and an upgraded Siri, but no in-lens AR display in its first generation, at an estimated $200–$500 price point.
  • More on-device AI processing, reducing lag and cloud dependence — Envision's April 2026 partnership with Arm and Google is a direct example.
  • Deeper mainstream/accessibility crossover, as companies like Meta continue to formalize accessibility features (vision settings, Be My Eyes integration, veteran donation programs) rather than leaving them to third-party apps.
  • Continued price competition pushing dedicated assistive glasses toward the sub-$500 range pioneered by Ally Solos, even as some legacy players like OrCam exit hardware development altogether.

Ask an AI Assistant to Help You Choose

Because the right device depends on your specific diagnosis, budget, and daily routine, an AI assistant can help you narrow the list faster than a general guide can. Try prompts like these:

  • Claude or ChatGPT: "I have [your eye condition] with [your visual acuity, if known]. My budget is $[X]. Compare eSight Go, Ally Solos, and Envision Glasses for my situation and explain the trade-offs."
  • Gemini: "Compare Android XR audio glasses (once available) with Meta's AI glasses lineup for someone with low vision, focused on accessibility features."
  • Perplexity: "Find current VA and vocational rehabilitation funding options for eSight Go or IrisVision Vista in [your state]."

Bring your specific diagnosis, remaining visual acuity, and budget to the conversation — that's what turns a generic answer into a genuinely useful recommendation.

Frequently Asked Questions

What's the best smart glasses for a totally blind person?
Dedicated AI-interpretation devices — Envision Glasses, Ally Solos, or a remaining OrCam MyEye 3 Pro unit — are built for this. Visual-enhancement devices like eSight Go and Acesight require some remaining usable vision and won't help someone with no light perception.

Are smart glasses for the visually impaired covered by insurance or the VA?
Sometimes. Many VA offices cover eSight Go and IrisVision Vista through clinician referral, Meta has been donating free Ray-Ban Meta AI glasses to legally blind veterans since June 2026, and state vocational rehabilitation programs frequently subsidize Envision and eSight devices. Vision-insurance coverage varies by plan.

What's the real difference between eSight and OrCam?
eSight Go enhances your existing vision on two OLED screens so you see more clearly yourself. OrCam MyEye doesn't display anything — it reads text and identifies people, objects, and products aloud, which is more useful if you have little or no usable vision. Keep in mind OrCam is selling through remaining dealer inventory rather than continuing active hardware development (see the note above).

Is OrCam still making new smart glasses in 2026?
No. OrCam closed its low-vision research and development division in July 2024 after three rounds of layoffs and shifted its focus entirely to hearing-aid technology under the OrCam Hear brand. The MyEye 3 Pro is still sold by several authorized U.S. resellers, but it reflects 2024-era hardware and software rather than ongoing 2026 development, and the company's long-term financial position has been reported as uncertain.

Can Meta's AI glasses replace a dedicated device like OrCam or Envision?
For many everyday tasks — reading a menu, identifying an object, getting a Be My Eyes volunteer — yes, and at a much lower price across Ray-Ban Meta, Meta Adventurer/Fury, or Meta Glasses by Kylie. But they're not purpose-built for accessibility: no dedicated OCR mode, no bone-conduction audio designed for blind users, and less specialized AI than Envision or Ally Solos for complex low-vision situations.

How much do smart glasses for the visually impaired cost in 2026?
From $299 (Meta Adventurer/Fury) and $399 (Ally Solos, Meta Glasses by Kylie) up to $3,689–$4,950 for dedicated medical-grade devices like OrCam MyEye 3 Pro and eSight Go. Financing plans and VA/vocational rehab funding can significantly reduce out-of-pocket cost.

What eye conditions can these devices help with?
Visual-enhancement devices (eSight, Acesight, NuEyes, IrisVision Vista) are commonly used for macular degeneration, diabetic retinopathy, Stargardt disease, and glaucoma with remaining central vision. AI-interpretation glasses (Envision, OrCam, Ally Solos, Meta's AI glasses) are used by anyone with severe vision loss or total blindness, regardless of the underlying cause.

Final Verdict

There is no single "best" smart glasses solution — only the right match for your visual needs and budget.

  • Best for seeing better: eSight Go
  • Best full-featured AI assistant: Envision Glasses
  • Best budget AI assistant: Ally Solos
  • Best discreet clip-on (with a caveat on company status): OrCam MyEye 3 Pro
  • Best affordable, everyday-looking option: Meta's Ray-Ban Meta, Meta Adventurer/Fury, or Meta Glasses by Kylie

Smart glasses remain one of the most impactful AI-powered assistive technologies in modern healthcare — and 2026's price competition, led by Meta and soon joined by Google and Samsung, is finally making that technology accessible to far more people, even as older specialists like OrCam step back from the category.

Related:

Affiliate Disclosure: Some links on OneDayAdvisor may be affiliate links, meaning we may earn a commission at no extra cost to you if you make a purchase. We only recommend products we believe add genuine value to our readers.

Disclaimer: This article is for educational and informational purposes and does not constitute medical advice. Pricing, specifications, company status, and funding eligibility change frequently — confirm current details directly with each manufacturer or an authorized distributor, and consult a low-vision specialist or ophthalmologist to determine which device fits your specific diagnosis.

Sources

  1. eSight Eyewear — official pricing, FAQ, Home Experience Program, and software update pages (esighteyewear.com)
  2. Envision — Ally Solos and Envision Glasses product and pricing pages (letsenvision.com)
  3. OrCam Technologies company history, layoffs, and 2024 pivot to hearing aids — Calcalist/CTech reporting and Wikipedia's OrCam device entry
  4. Meta Newsroom — "The Future Is for Everyone: Free AI Glasses for Every Blind Veteran in America" (about.fb.com)
  5. Meta and EssilorLuxottica — Meta Glasses (Adventurer, Fury, Kylie) launch coverage, June 2026
  6. Google I/O 2026 and Samsung Galaxy Unpacked July 2026 — Android XR glasses announcements
  7. Bloomberg (Mark Gurman) via multiple outlets — Apple N50 smart glasses timeline reporting, July 2026
  8. American Foundation for the Blind, AccessWorld — Ray-Ban Meta AI glasses review
  9. JAMA Ophthalmology (2016) — portable artificial vision device study.

Comments

Post a Comment

Labels

Show more

Archive

Show more

Popular posts from this blog

Dr William Makis Ivermectin Protocol 2026 – Complete Guide + Patient Outcomes

-
Image
Medically Reviewed by: Dr Frank Yap, MD | Written by:     OneDayMD Editorial Team | Last Updated:   September  2026 Dr. William Makis MD (McGill Medicine, 110+ peer-reviewed publications) has treated a large volume of cancer patients using repurposed drugs since 2023 and has documented outcomes publicly on Substack and X. This continuously updated 2026 guide compiles Dr. Makis's latest protocols (from his Substack, X posts through 2026, and direct patient correspondence). We cross-reference his exact dosages, schedules, combinations, safety data, sourcing, and real patient outcomes (anonymized but verifiable on his channels). Important Disclaimer: This content is for educational purposes only and does not constitute medical advice. Ivermectin is used off-label for cancer treatment. Always consult with a knowledgeable physician whom you trust to manage your health. Individual results may vary. Do not self-medicate with ivermectin without proper bloodwork and medica...
Read more

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2026)

-
Image
Medically Reviewed by: Dr Frank Yap, MD | Written by:     OneDayMD Editorial Team | Last Updated:   September  2026 If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories  and a recent peer-reviewed publication, " Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients : Results from a Prospective Observational Cohort ( Anticancer Research 2026 )" We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a s...
Read more

DMSO 101: Benefits, Uses, Dosage and Side Effects (2026)

-
Image
Quick Summary: DMSO (Dimethyl Sulfoxide) is a naturally occurring compound with decades of research behind its use as an anti-inflammatory, analgesic, and cellular-protective agent. FDA-approved for interstitial cystitis, it has been used off-label by athletes, physicians, and patients for musculoskeletal injuries, chronic pain, wound healing, and more. This guide covers what DMSO is, how it works, the evidence for its key uses, safety considerations, dosing guidance, and where to find practitioners who use it. All off-label uses are experimental. Consult a qualified healthcare provider before use. A Patient Story: From Lung Transplant List to Clear CT Scans In 2022, Erica Eyres, a vigorous fifty-six-year-old aerobics instructor who had struggled to breathe, was given “absolutely devastating” news: She might need a lung transplant. She had never smoked, ran cross-country track in high school, and was a personal trainer for years, but, by 2024, a transplant assessment was arranged. “I d...
Read more

How to Get Ivermectin in the US: Pharmacies, Legal Status & State-by-State Access (2026)

-
Image
Medically Reviewed by: OneDayMD Editorial Team | Last Updated: August 2026 An updated, evidence-based guide to ivermectin's federal and state legal status, how to obtain a prescription, which states allow pharmacist-dispensed or OTC access, and a directory of pharmacies that fill ivermectin prescriptions in the US. Quick Answer (AI & Search Summary) Ivermectin is still classified federally as a prescription-only drug for human use. It has not been reclassified as OTC by the FDA. However, five states — Arkansas, Idaho, Louisiana, Tennessee, and Texas — have passed laws letting pharmacists dispense it without a doctor's prescription, and roughly half a dozen more have active bills. Everywhere else, you need a prescription from a doctor, urgent care provider, or telehealth service. Individual pharmacists retain the right to decline to dispense or stock it even where state law allows it. Table of Contents Current Legal Status (Federal & State) State-by-...
Read more

Fenbendazole, Ivermectin and Mebendazole for Cancer: Case Series of 760+ Case Reports (September 2026 Update)

-
Image
Medically Reviewed by: OneDayMD Editorial Team | Last Updated: August 2026 Table of Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories (130 cases) Brain Cancer (including Glioblastoma) (135 cases) Bladder Cancer Success Stories  (including kidney cancer) (37 cases) Cervical Cancer  (6 cases) Colorectal Cancer  (including Appendix cancer) (85 cases) Esophageal and Stomach cancer (23 cases) Endometrial Cancer (13 cases) Gastric (Stomach) cancer (see  Esophageal and Stomach Cancer )  Head and Neck Cancer (17 cases) Kidney Cancer Case Series  (including urinary (urothelial) bladder cancer) Liver and Bile Duct Cancer  (Hepato-biliary system) (9 cases) Lung Cancer (62 cases) Leukemia (13 cases) Lymphoma (28 cases) Melanoma (refer to ...
Read more

Ivermectin, Fenbendazole and Mebendazole: A Peer-Reviewed Protocol for Cancer Treatment (2026 Update)

-
Image
Medically Reviewed by: OneDayMD Editorial Team | Last Updated: April 2026 In September 2024, a first-of-its-kind protocol utilizing ivermectin, fenbendazole, and mebendazole for cancer treatment was peer-reviewed and officially published in the Journal of Orthomolecular Medicine . Led by researchers Dr. Ilyes Baghli, Dr. Pierrick Martinez, and FLCCC's Dr. Paul Marik, the protocol applies antiparasitic drugs — originally developed to combat parasites — to cancer treatment, building on emerging preclinical and clinical evidence of their anticancer properties. This trio of repurposed drugs has been shown to disrupt the growth of cancer cells, particularly by targeting microtubules, the essential structures that allow cancer to multiply uncontrollably. What makes this protocol even more potent is the synergistic effect when these drugs are used together, creating a powerful new affordable weapon against cancer. Journal of Orthomolecular Medicine 2024 Targeting the Mitochondrial-Stem C...
Read more

Best Ivermectin Dosage for Humans with Cancer or Different Cancer Types (2026)

-
Image
Medically Reviewed by:  Dr Frank Yap, MD  | Written by:     OneDayMD Editorial Team | Last Updated:   August 2026 This article discusses dosage considerations and key factors related to the use of ivermectin in cancer treatment. Much of the publicly available information regarding ivermectin dosage is based on the standard dosing recommendations developed by Merck for the treatment of parasitic infections. These dosages are often cited without distinction from the higher or alternative dosing regimens that have been explored in cancer-related research. Dosages used for parasitic infections may not correspond to those investigated in oncology studies. Potential dosing strategies may vary depending on several factors, including the patient's body weight, cancer type, cancer stage and grade, overall health status, and liver function. ...
Read more

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

-
Image
Medically Reviewed by: Dr Frank Yap, MD | Written by: OneDayMD Editorial Team | Last Updated: July 30, 2026 Ivermectin Resources I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. Update - Cautionary Remark by Dr Paul Marik ( Substack June 2026 ): Protocol (above and below) is a potentially toxic dosing protocol which we Do NOT Recommend Updated version An article and a video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose Ivermectin and Cancer .  2025 - 2026 studies on ivermectin for cancer Clinical Hulscher et al -  Real-World Clinical Out...
Read more

Best Fenbendazole Dosage for Humans: Safety, Side Effects and Efficacy Examined (2026)

-
Image
Fenbendazole is a broad spectrum anti-parasitic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. (2) Fenbendazole, has garnered ⁤attention​ for its potential use ​in‍ humans.‍ The Fenbendazole Cancer Protocol gained rapid interest over the past years following some fenbendazole advanced cancer success stories  (more than 500 case reports). Joe Tippens founded the protocol  after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different m...
Read more